|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Methamphetamine
|
NIAAA
|
1R13DA022908-01
|
|
Toward An Integrative Behavioral Health Services Research Platform
|
GONZALES, JUNIUS
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$20,000
|
|
Methamphetamine
|
NIDA
|
1R13DA022908-01
|
|
Toward An Integrative Behavioral Health Services Research Platform
|
GONZALES, JUNIUS
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$48,648
|
|
Methamphetamine
|
NIMH
|
1R13DA022908-01
|
|
Toward An Integrative Behavioral Health Services Research Platform
|
GONZALES, JUNIUS
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$30,000
|
|
Methamphetamine
|
NIDA
|
1R03DA023393-01
|
|
Behavioral activation and HIV risk reduction for MSM with crystal meth abuse
|
MIMIAGA, MATTHEW
|
FENWAY COMMUNITY HEALTH CENTER
|
MA
|
$75,350
|
|
Methamphetamine
|
NIEHS
|
5K99ES015428-02
|
|
Assessment of Psychostimulant Addiction Risk Following Developmental PCB Exposure
|
SABLE, HELEN
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$90,000
|
|
Methamphetamine
|
NIDA
|
1R01DA023964-01
|
|
Rivastigmine as a Treatment for Methamphetamine Dependence
|
DE LA GARZA, RICHARD
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$383,750
|
|
Methamphetamine
|
NIDA
|
5F30DA021961-02
|
|
Methamphetamine Dependence and Emotion Regulation
|
BAICY, KATE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$38,289
|
|
Methamphetamine
|
NIDA
|
5R01DA018625-03
|
|
Secondary Analysis of Substance Use In Men
|
FENDRICH, MICHAEL
|
UNIVERSITY OF WISCONSIN MILWAUKEE
|
WI
|
$207,269
|
|
Methamphetamine
|
NIDA
|
5K25DA021112-03
|
|
MR Spectroscopy to Study Brain Glutamate in HIV/AIDS and Methamphetamine Users
|
SAILASUTA, NAPAPON
|
HUNTINGTON MEDICAL RESEARCH INSTITUTES
|
CA
|
$179,357
|
|
Methamphetamine
|
NIDA
|
2R01DA001568-29A2
|
|
Behavioral Characterization of Acute and Chronic Amphetamine
|
KUCZENSKI, RONALD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$386,538
|
|
Methamphetamine
|
NIDA
|
2R01DA012204-09A1
|
|
Methamphetamine Abuse and Cortical Cell Injury
|
MARSHALL, JOHN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$300,410
|
|
Methamphetamine
|
NIDA
|
5R01DA004222-22
|
|
"Neurochemical Alterations By Designer Drugs"
|
HANSON, GLEN
|
UNIVERSITY OF UTAH
|
UT
|
$213,392
|
|
Methamphetamine
|
NIDA
|
5R01DA006733-16
|
|
Developmental Effects of Methamphetamine-like Stimulants
|
VORHEES, CHARLES
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$276,906
|
|
Methamphetamine
|
NIDA
|
1R03DA021385-01A2
|
|
Mitochondrial Injury in Methamphetamine-Induced Neurodegeneration
|
KUSHNAREVA, YULIA
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$94,500
|
|
Methamphetamine
|
NIDA
|
5R01DA017327-04
|
|
Methamphetamine Neurotoxicity and Microglial Activation
|
KUHN, DONALD
|
WAYNE STATE UNIVERSITY
|
MI
|
$295,459
|
|
Methamphetamine
|
NIDA
|
5R01DA018682-07
|
|
Psychostimulant Recognition by Serotonin Transporters
|
BARKER, ERIC
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$209,177
|
|
Methamphetamine
|
NIDA
|
5F32DA020306-03
|
|
Amphetamine Regulation of the Norepinephrine Transporter
|
ERREGER, KEVIN
|
VANDERBILT UNIVERSITY
|
TN
|
$49,928
|
|
Methamphetamine
|
NIDA
|
5R01DA011560-10
|
|
Antibody-based Therapy for Methamphetamine Abuse
|
OWENS, S.
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$458,481
|
|
Methamphetamine
|
NIDA
|
5R01DA002486-28
|
|
Primate Model of Drug Abuse: Intervention Strategies
|
CARROLL, MARILYN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$402,903
|
|
Methamphetamine
|
NIDA
|
5R01DA010072-10
|
|
Dopamine Partial Agonists and Psychostimulant Dependence
|
KOOB, GEORGE
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$365,344
|
|
Methamphetamine
|
NIDA
|
5R01DA019627-04
|
|
Dopamine regulates drug and social reward interactions
|
WANG, ZUOXIN
|
FLORIDA STATE UNIVERSITY
|
FL
|
$232,370
|
|
Methamphetamine
|
NIDA
|
5R01DA000869-32
|
|
Drug Abuse and Regulatory Enzymes of Biogenic Amines
|
FLECKENSTEIN, ANNETTE
|
UNIVERSITY OF UTAH
|
UT
|
$284,522
|
|
Methamphetamine
|
NIDA
|
5R01DA016776-03
|
|
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
|
MENDELSON, JOHN
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$415,799
|
|
Methamphetamine
|
NIDA
|
5R01DA010756-10
|
|
Neurotoxic Amphetamines Radicals & 5HT Neurons
|
KUHN, DONALD
|
WAYNE STATE UNIVERSITY
|
MI
|
$328,745
|
|
Methamphetamine
|
NIDA
|
5R01DA020142-03
|
|
Methamphetamine and the Striatal NK-1 Receptors
|
ANGULO, JESUS
|
HUNTER COLLEGE
|
NY
|
$217,684
|
|
Methamphetamine
|
NIDA
|
5K05DA015267-07
|
|
Animal Models for the Prevention and Treatment of Drug Abuse
|
CARROLL, MARILYN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$138,988
|
|
Methamphetamine
|
NIDA
|
5K01DA021699-02
|
|
Methamphetamine Effects on Dendrodendritic Dopamine Transmission in the VTA
|
BECKSTEAD, MICHAEL
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$135,669
|
|
Methamphetamine
|
NIDA
|
5R01DA007606-16
|
|
Methamphetamine Toxicity and Corticostriatal Glutamate
|
YAMAMOTO, BRYAN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$181,851
|
|
Methamphetamine
|
NIDA
|
5R01DA017711-04
|
|
Stimulant Abuse Pharmacotherapy: Novel Antipsychotics
|
RUSH, CRAIG
|
UNIVERSITY OF KENTUCKY
|
KY
|
$306,293
|
|
Methamphetamine
|
NIDA
|
1F32DA024533-01
|
|
Mesolimbic Dopamine Modulation of Cue-Enhanced Ventral Pallidal Activity
|
TAYLOR, JENNIFER
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$49,646
|
|
Methamphetamine
|
NIDA
|
5K01DA017647-03
|
|
Women, Methamphetamine and Sex
|
BROWN, ALISON
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$116,777
|
|
Methamphetamine
|
NIDA
|
5F31DA021475-02
|
|
GABABeta Regulation of METH-Induced Associative Learning
|
VOIGT, ROBIN
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$25,753
|
|
Methamphetamine
|
NIDA
|
5R01DA021287-02
|
|
Prenatal IV nicotine: Long-term vulnerability to stimulant drugs
|
HARROD, STEVEN
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$246,960
|
|
Methamphetamine
|
NIDA
|
1F32DA024542-01
|
|
The Influence of Sex on the Circadian Response to Methamphetamine
|
MOHAWK, JENNIFER
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$48,047
|
|
Methamphetamine
|
NIDA
|
5K08DA022946-02
|
|
Impairment of Adult Hippocampal Neurogenesis by Methamphetamines and HIV
|
VENKATESAN, ARUN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$184,248
|
|
Methamphetamine
|
NIDA
|
5R01DA022541-03
|
|
The Neural Bases of Affect Regulation in Drug Abuse
|
OCHSNER, KEVIN
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$339,170
|
|
Methamphetamine
|
NIDA
|
5R01DA003982-24
|
|
Psychostimulant Effects on Striatal Signaling
|
MCGINTY, JACQUELINE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$286,160
|
|
Methamphetamine
|
NIDA
|
5R03DA018279-02
|
|
Behavioral Effects of Neonatal Methamphetamine Exposure
|
DOMINGUEZ, HECTOR
|
SAN DIEGO STATE UNIVERSITY
|
CA
|
$73,255
|
|
Methamphetamine
|
NIDA
|
5R37DA023142-02
|
|
Cannabinergic Medications for Methamphetamine Addiction
|
MAKRIYANNIS, ALEXANDROS
|
NORTHEASTERN UNIVERSITY
|
MA
|
$672,538
|
|
Methamphetamine
|
NIDA
|
5R01DA004130-20
|
|
Anorectic Drugs: Abuse and Behavioral Mechanisms of Action
|
FOLTIN, RICHARD
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$264,068
|
|
Methamphetamine
|
NIDA
|
5K05DA000378-08
|
|
Pharmacology and Toxicology of Methamphetamine Abuse (K05 DA00378)
|
HANSON, GLEN
|
UNIVERSITY OF UTAH
|
UT
|
$129,600
|
|
Methamphetamine
|
NIDA
|
5K05DA017964-04
|
|
Studies of Substituted Amphetamine Neurotoxicity
|
RICAURTE, GEORGE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$128,902
|
|
Methamphetamine
|
NIDA
|
5R01DA019502-03
|
|
High-speed detection of stimulant-induced cortical ACh release
|
BRUNO, JOHN
|
OHIO STATE UNIVERSITY
|
OH
|
$305,900
|
|
Methamphetamine
|
NIDA
|
5R01DA017366-05
|
|
The PTP, STEP, Regulates Amphetamine Actions
|
LOMBROSO, PAUL
|
YALE UNIVERSITY
|
CT
|
$303,853
|
|
Methamphetamine
|
NINDS
|
5K02NS052536-03
|
|
Presynaptic Regulation of Striatal Excitation
|
BAMFORD, NIGEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$152,797
|
|
Methamphetamine
|
NIDA
|
1K01DA024577-01
|
|
Methamphetamine and HIV-1 Infection: Targeted Nanoparticles for Gene Silencing.
|
REYNOLDS, JESSICA
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$151,067
|
|
Methamphetamine
|
NIDA
|
5K01DA020680-02
|
|
Molecular Mechanisms of Methamphetamine Neurotoxicity
|
THOMAS, DAVID
|
WAYNE STATE UNIVERSITY
|
MI
|
$114,972
|
|
Methamphetamine
|
NIDA
|
5R03DA022128-02
|
|
Wyoming Meth Use and AIDS Risk: Exploring Rural Culture and Context (WyMAR)
|
BOWEN, ANNE
|
UNIVERSITY OF WYOMING
|
WY
|
$70,070
|
|
Methamphetamine
|
NIDA
|
5R01DA021115-03
|
|
Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
|
PATTERSON, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$584,639
|
|
Methamphetamine
|
NIDA
|
5R21DA022125-02
|
|
MSM Communities in NYC Respond to HIV and Methamphetamine
|
BRAINE, NAOMI
|
BETH ISRAEL MEDICAL CTR (NEW YORK)
|
NY
|
$191,222
|
|
Methamphetamine
|
NIDA
|
5R01DA016283-05
|
|
DIENCEPHALIC MECHANISMS OF DRUG ABUSE
|
GLICK, STANLEY
|
ALBANY MEDICAL COLLEGE
|
NY
|
$256,929
|
|
Methamphetamine
|
NIDA
|
5K01DA020364-04
|
|
Using GIS to Study IDU Risk Environments in Tijuana
|
BROUWER, KIMBERLY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$164,048
|
|
Methamphetamine
|
NIDA
|
5F31DA022834-02
|
|
Viral-Mediated Alterations in CaMKII Alter Behavioral Responding to Amphetamine
|
LOWETH, JESSICA
|
UNIVERSITY OF CHICAGO
|
IL
|
$33,869
|
|
Methamphetamine
|
NIDA
|
5R01DA002812-26
|
|
Determinants of Drug Preference in Humans
|
DE WIT, HARRIET
|
UNIVERSITY OF CHICAGO
|
IL
|
$382,009
|
|
Methamphetamine
|
NIDA
|
5R01DA019559-04
|
|
Intranasal Methamphetamine: A Pharmacotherapy Model
|
HART, CARL
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$506,193
|
|
Methamphetamine
|
NIDA
|
1R03DA024702-01
|
|
Development of Levocabastine Analogues to Treat Methamphetamine Abuse
|
THOMAS, JAMES
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$270,033
|
|
Methamphetamine
|
NIDA
|
1R01DA024705-01
|
|
Immunopharmacotherapy for Methamphetamine Addiction
|
TAFFE, MICHAEL
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$426,375
|
|
Methamphetamine
|
NIDA
|
1R03DA023438-01A1
|
|
Methamphetamine use in inmates: risk behaviors, health status and recidivism
|
WHITE, MARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$77,146
|
|
Methamphetamine
|
NIDA
|
1R21DA024800-01
|
|
Quantitative Drug Surveillance System Development
|
BANTA-GREEN, CALEB
|
UNIVERSITY OF WASHINGTON
|
WA
|
$220,635
|
|
Methamphetamine
|
NIDA
|
5R01DA013975-09
|
|
Amphetamine Regulation of Dopamine Transport
|
GALLI, AURELIO
|
VANDERBILT UNIVERSITY
|
TN
|
$292,720
|
|
Methamphetamine
|
FIC
|
5R21DA021422-02
|
|
Brain Changes with Cannabis and Methamphetamine
|
YURGELUN-TODD, DEBORAH
|
MC LEAN HOSPITAL (BELMONT, MA)
|
MA
|
$1,000
|
|
Methamphetamine
|
NIDA
|
5R21DA021422-02
|
|
Brain Changes with Cannabis and Methamphetamine
|
YURGELUN-TODD, DEBORAH
|
MC LEAN HOSPITAL (BELMONT, MA)
|
MA
|
$7,073
|
|
Methamphetamine
|
NIDA
|
5R01DA022155-03
|
|
Mirtazapine to Reduce Methamphetamine Use Among MSM with High-Risk HIV Behaviors
|
COLFAX, GRANT
|
PUBLIC HEALTH FOUNDATION ENTERPRISES
|
CA
|
$355,912
|
|
Methamphetamine
|
NIDA
|
1R21DA024845-01
|
|
Novel Methods to Map Stimulant QTLs in Advanced Intercross Lines
|
PALMER, ABRAHAM
|
UNIVERSITY OF CHICAGO
|
IL
|
$268,625
|
|
Methamphetamine
|
NIDA
|
2R01DA010355-13A1
|
|
Metabotropic Glutamate Regulation of Amphetamine Action
|
WANG, QIANG
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
MO
|
$335,250
|
|
Methamphetamine
|
NIDA
|
5R01DA011697-08
|
|
Pharmacology of Dopamine Release by Amphetamine
|
GNEGY, MARGARET
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$437,686
|
|
Methamphetamine
|
NIDA
|
5R01DA018307-05
|
|
STIMULANT DEPENDENCE: NEURAL MECHANISMS OF RELAPSE
|
PAULUS, MARTIN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$251,237
|
|
Methamphetamine
|
NIDA
|
5R01DA007610-15
|
|
Immunotherapy for Drug Abuse
|
OWENS, S.
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$429,148
|
|
Methamphetamine
|
NIDA
|
5R01DA021870-02
|
|
Modulation of Methamphetamine Actions in the CNS
|
DUBOCOVICH, MARGARITA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$295,960
|
|
Methamphetamine
|
NIDA
|
5R01DA021336-03
|
|
Mouse QTL and Human Association Study of Methamphetamine Sensitivity
|
PALMER, ABRAHAM
|
UNIVERSITY OF CHICAGO
|
IL
|
$328,653
|
|
Methamphetamine
|
NIDA
|
5R01DA019921-04
|
|
Neural Sensitivity to Stress During Drug Withdrawal
|
FORSTER, GINA
|
UNIVERSITY OF SOUTH DAKOTA
|
SD
|
$223,722
|
|
Methamphetamine
|
NIDA
|
2R01DA015169-06A2
|
|
Trafficking and Regulation of Monoamine Transporters
|
MELIKIAN, HALEY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$354,375
|
|
Methamphetamine
|
NINDS
|
1R01NS056181-01A2
|
|
Susceptibility of Primate Dopamine Neurons to Toxicity During Development
|
ELSWORTH, JOHN
|
YALE UNIVERSITY
|
CT
|
$362,031
|
|
Methamphetamine
|
NIDA
|
1R01DA023468-01A1
|
|
An ACE Inhibitor as a Treatment for Methamphetamine Dependence
|
NEWTON, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$383,750
|
|
Methamphetamine
|
NIDA
|
1R01DA023567-01A1
|
|
A dose ranging study of modafinil for methamphetamine dependence
|
GALLOWAY, GANTT
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$507,611
|
|
Methamphetamine
|
NIDA
|
1K23DA023558-01A1
|
|
Pharmacogenomics and Medication Development for Methamphetamine Dependence
|
HEINZERLING, KEITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$169,668
|
|
Methamphetamine
|
NIDA
|
1R21DA023686-01A1
|
|
RNAi knockdown of Cav1.3 and addiction
|
RAJADHYAKSHA, ANJALI
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$252,000
|
|
Methamphetamine
|
NIDA
|
1R24DA021471-01A1
|
|
Methamphetamine Research Program at Meharry Medical College
|
RUCKER, HUBERT
|
MEHARRY MEDICAL COLLEGE
|
TN
|
$428,060
|
|
Methamphetamine
|
NIDA
|
5R01DA009397-12
|
|
Sensitization and Stimulant Self-Administration
|
VEZINA, PAUL
|
UNIVERSITY OF CHICAGO
|
IL
|
$271,906
|
|
Methamphetamine
|
NIDA
|
1R03DA023471-01A1
|
|
Future Probability and Past Discounting by Active Methamphetamine Users
|
YI, RICHARD
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$72,375
|
|
Methamphetamine
|
NIDA
|
5R01DA022190-03
|
|
Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM
|
COLFAX, GRANT
|
PUBLIC HEALTH FOUNDATION ENTERPRISES
|
CA
|
$273,804
|
|
Methamphetamine
|
NIDA
|
5R21DA022314-02
|
|
Calcitriol and Methamphetamine Neurotoxicity
|
CASS, WAYNE
|
UNIVERSITY OF KENTUCKY
|
KY
|
$179,463
|
|
Methamphetamine
|
NIDA
|
5K01DA022473-02
|
|
Regulation of Adult Neurogenesis by Methamphetamine
|
MANDYAM, CHITRA
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$154,900
|
|
Methamphetamine
|
NINDS
|
5K02NS045798-05
|
|
The mechanism of MPTP resistance in synuclein null mice.
|
DAUER, WILLIAM
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$120,035
|
|
Methamphetamine
|
NIDA
|
5R01DA021100-03
|
|
Correlates of Sexual Risk for HIV/STI Among Women Who Use Methamphetamine
|
KRAL, ALEXANDER
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$510,211
|
|
Methamphetamine
|
NIDA
|
5R01DA003240-25
|
|
Vulnerability to Drug Abuse and Treatment Efficacy: Animal Models
|
CARROLL, MARILYN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$319,519
|
|
Methamphetamine
|
NIDA
|
5R01DA003476-23
|
|
Drug Effects on Behavior: Workplace Implications
|
HART, CARL
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$490,219
|
|
Methamphetamine
|
NIDA
|
5K02DA023048-02
|
|
Dopamine Regulates Drug and Social Reward Interactions
|
WANG, ZUOXIN
|
FLORIDA STATE UNIVERSITY
|
FL
|
$114,849
|
|
Methamphetamine
|
NIDA
|
5R01DA019912-02
|
|
Parallel MRI for High Field Neuroimaging
|
STENGER, VICTOR
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$287,577
|
|
Methamphetamine
|
NIDA
|
1F31DA024885-01
|
|
Phosphatidylinositol 3 Kinase Signaling Regulates the Amphetamine Actions
|
SPEED, NICOLE
|
VANDERBILT UNIVERSITY
|
TN
|
$25,574
|
|
Methamphetamine
|
NIDA
|
1F32DA024920-01
|
|
Genetic Variation in Amphetamine Response
|
HAMIDOVIC, AJNA
|
UNIVERSITY OF CHICAGO
|
IL
|
$60,427
|
|
Methamphetamine
|
NIDA
|
5R01DA020725-02
|
|
Imaging Individual Differences In Amphetamine Effects
|
WHITE, TARA
|
BROWN UNIVERSITY
|
RI
|
$347,979
|
|
Methamphetamine
|
NIDA
|
5R01DA021016-04
|
|
Early brain development after prenatal "Ice" exposure: A Longitudinal MR study
|
CHANG, LINDA
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$533,512
|
|
Methamphetamine
|
NIDA
|
5U54NS056883-02
|
|
Imaging Studies in Neurotoxicity and Neurodevelopment
|
CHANG, LINDA
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$485,450
|
|
Methamphetamine
|
NINDS
|
5U54NS056883-02
|
|
Imaging Studies in Neurotoxicity and Neurodevelopment
|
CHANG, LINDA
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$1,179,993
|
|
Methamphetamine
|
NIDA
|
5K02DA022346-02
|
|
Treating Adolsecent and Adult Methamphetamine or Inhalant Abuse with S-(+)-GVG
|
DEWEY, STEPHEN
|
BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB
|
NY
|
$134,136
|
|
Methamphetamine
|
NIDA
|
5R01DA013519-08
|
|
Development of Novel Therapies or Methamphetamine Abuse
|
DWOSKIN, LINDA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$545,671
|
|
Methamphetamine
|
NIDA
|
5R21DA023192-02
|
|
Magnetic Resonance Spectroscopic Imaging of the Brain in Methamphetamine Abuse
|
O'NEILL, JOSEPH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$226,380
|
|
Methamphetamine
|
NIDA
|
5R01DA021695-02
|
|
Development of a Family-Based Treatment for Adolescent Methamphetamine Abuse
|
WALDRON, HOLLY
|
OREGON RESEARCH INSTITUTE
|
OR
|
$639,334
|
|
Methamphetamine
|
NIDA
|
5R01DA022936-02
|
|
Long Term Health Effects of Methamphetamine Use in the MACS
|
STALL, RON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$503,914
|
|
Methamphetamine
|
NIMH
|
5R01MH061146-08
|
|
Reducing HIV/STD risk, methamphetamine use, and depression among heterosexuals
|
PATTERSON, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$560,753
|
|
Methamphetamine
|
NIDA
|
5R21DA022323-02
|
|
Methamphetamine Effects via Trace Amine Associated Receptor 1
|
MILLER, GREGORY
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$212,538
|
|
Methamphetamine
|
NIDA
|
2P01DA013367-06A2
|
0005
|
DEVELOPMENTAL REFRACTORINESS
|
FLECKENSTEIN, ANNETTE
|
UNIVERSITY OF UTAH
|
UT
|
$149,972
|
|
Methamphetamine
|
NIDA
|
2P01DA013367-06A2
|
0006
|
LESION-INDUCED REFRACTORINESS IN ADULTS
|
KEEFE, KRISTEN
|
UNIVERSITY OF UTAH
|
UT
|
$181,799
|
|
Methamphetamine
|
NIDA
|
2P01DA013367-06A2
|
0007
|
TOLERANCE-RELATED REVERSIBLE REFRACTORINESS
|
WILKINS, DIANA
|
UNIVERSITY OF UTAH
|
UT
|
$167,408
|
|
Methamphetamine
|
NIDA
|
5R01DA020726-04
|
|
Neural Systems, Inhibitory Control, and Methamphetamine Dependence
|
LONDON, EDYTHE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$448,459
|
|
Methamphetamine
|
NIDA
|
5R01DA021757-02
|
|
Prenatal Methamphetamine Exposure and Child Development in New Zealand and USA
|
LAGASSE, LINDA
|
WOMEN AND INFANTS HOSPITAL-RHODE ISLAND
|
RI
|
$365,705
|
|
Methamphetamine
|
NIDA
|
5R21DA023399-02
|
|
Reducing HIV Risk Among Methamphetamine IDUs Through Peer Education
|
RUMPTZ, MAUREEN
|
MULTNOMAH COUNTY HEALTH DEPARTMENT
|
OR
|
$150,780
|
|
Methamphetamine
|
NIDA
|
5K02DA020569-03
|
|
Parallel MRI for Substance Abuse Research
|
STENGER, VICTOR
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$158,687
|
|
Methamphetamine
|
NIDA
|
5R21DA021113-02
|
|
Do Psychostimulatory Drugs Enhance Lentivirus Infection?
|
MATHES, LAWRENCE
|
OHIO STATE UNIVERSITY
|
OH
|
$183,750
|
|
Methamphetamine
|
NIDA
|
5R01DA021537-04
|
|
Immunopathogenesis of HIV-1 Infection: Role of Methamphetamine
|
NAIR, MADHAVAN
|
FLORIDA INTERNATIONAL UNIVERSITY
|
FL
|
$403,015
|
|
Methamphetamine
|
NIDA
|
1R03DA024998-01
|
|
Examining the role of venues in structuring sexual and drug-use networks among MS
|
FROST, SIMON
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$154,500
|
|
Methamphetamine
|
NIMH
|
5F31MH073430-04
|
|
Sexual HIV risk among Thai methamphetamine users
|
GERMAN, DANIELLE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$44,576
|
|
Methamphetamine
|
NIDA
|
5R01DA023916-02
|
|
Development of Cannabinoid Receptor Based Medications for Drug Addiction
|
TRUDELL, MARK
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$341,795
|
|
Methamphetamine
|
NIDA
|
5R21DA024341-02
|
|
Assessing the Development of Drug Markets Using Bayesian Space-Time Models
|
GRUENEWALD, PAUL
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
MD
|
$236,971
|
|
Methamphetamine
|
NIDA
|
5R21DA024391-02
|
|
The Dynamics of Methamphetamine Markets: A Systematic Approach to the Process
|
BROWNSTEIN, HENRY
|
NATIONAL OPINION RESEARCH CENTER
|
IL
|
$211,680
|
|
Methamphetamine
|
NIDA
|
5R01DA014948-08
|
|
Prenatal Methamphetamine Exposure and School Aged Outcome
|
LESTER, BARRY
|
WOMEN AND INFANTS HOSPITAL-RHODE ISLAND
|
RI
|
$1,435,676
|
|
Methamphetamine
|
NIDA
|
5R01DA017830-05
|
|
Longitudinal MRI in Prenatal Methamphetamine or Alcohol Exposure
|
SOWELL, ELIZABETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$438,925
|
|
Methamphetamine
|
NIDA
|
5R21DA024443-02
|
|
Methamphetamine, HIV, Neuroinflammation and Behavior
|
JOHNSON, RODNEY
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$187,425
|
|
Methamphetamine
|
NIDA
|
5R21DA024381-02
|
|
Drug Market Characteristics: Antecedents and Sequelae on the U.S. Mexico Border
|
STRATHDEE, STEFFANIE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$221,326
|
|
Methamphetamine
|
NIDA
|
5R21DA023473-02
|
|
EPR Imaging of Brain O2 in Drug Abuse
|
ROSEN, GERALD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$159,233
|
|
Methamphetamine
|
NIDA
|
5R01DA014702-07
|
|
Preventing Rural Thai Methamphetamine Abuse and HIV by Community Mobilization
|
CELENTANO, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$474,904
|
|
Methamphetamine
|
NIDA
|
7R01DA024467-02
|
|
Methamphetamine/SIV Interaction in the CNS
|
FOX, HOWARD
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$363,825
|
|
Methamphetamine
|
NIDA
|
5R01DA023395-02
|
|
Intervention Targeting Medication Adherence and Methamphetamine Use for HIV + Men
|
PARSONS, JEFFREY
|
HUNTER COLLEGE
|
NY
|
$565,956
|
|
Methamphetamine
|
NIDA
|
5R21DA020551-02
|
|
Rural Methamphetamine-Abusing Parents and Their Children
|
HAIGHT, WENDY
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$233,242
|
|
Methamphetamine
|
NIDA
|
5R01DA024441-02
|
|
Methamphetamine, Stress and SIV: Effects at Blood-Brain Barrier and Lymph Nodes
|
CAPITANIO, JOHN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$636,420
|
|
Methamphetamine
|
NIDA
|
5R01DA022476-02
|
|
Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
|
RIES, RICHARD
|
UNIVERSITY OF WASHINGTON
|
WA
|
$466,132
|
|
Methamphetamine
|
NIDA
|
5K23DA020801-03
|
|
Neurodevelopment of Methamphetamine Exposed Children
|
DERAUF, D
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$170,392
|
|
Methamphetamine
|
NIDA
|
5R21DA024165-02
|
|
The Role of Dopamine Transporter Trafficking in Psychostimulant Addiction
|
MELIKIAN, HALEY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$159,250
|
|
Methamphetamine
|
NIDA
|
5R01DA021330-02
|
|
Understanding the Scope and Magnitude of Prescription Drug Diversion
|
INCIARDI, JAMES
|
UNIVERSITY OF DELAWARE
|
DE
|
$647,263
|
|
Methamphetamine
|
NIDA
|
5U01DA023900-02
|
|
Active Immunization for Treating Methamphetamine Abuse
|
OWENS, S.
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$957,317
|
|
Methamphetamine
|
NIDA
|
5R21DA024235-02
|
|
MR Assessment of Altered Cerebral Gene Expression after Amphetamine Exposure
|
LIU, CHRISTINA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$213,868
|
|
Methamphetamine
|
NIDA
|
2R01DA012460-06A1
|
|
Dopamine D2 Receptors in Primate Models of Cocaine Abuse
|
NADER, MICHAEL
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$424,689
|
|
Methamphetamine
|
NIDA
|
1R01DA024080-01A1
|
|
Executive Function Therapy for Stimulant Addiction
|
BICKEL, WARREN
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$571,167
|
|
Methamphetamine
|
NIDA
|
1R01DA024070-01A1
|
|
Longitudinal neuroimaging of metamphetamine-dependent adolescents
|
RENSHAW, PERRY
|
UNIVERSITY OF UTAH
|
UT
|
$284,575
|
|
Methamphetamine
|
NIDA
|
1R01DA024036-01A1
|
|
Long-term consequences of methamphetamine toxicity
|
KEEFE, KRISTEN
|
UNIVERSITY OF UTAH
|
UT
|
$344,419
|
|
Methamphetamine
|
NIDA
|
1K99DA023085-01A2
|
|
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)
|
MOSZCZYNSKA, ANNA
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$89,640
|
|
Methamphetamine
|
NIDA
|
5F31DA023883-02
|
|
Understanding Risk-Taking Behavior: Acute of Intranasal Methamphetamine
|
KIRKPATRICK, MATTHEW
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$40,972
|
|
Methamphetamine
|
NIDA
|
1R41DA023311-01A2
|
|
Substance Abuse Diagnostic Clinical Interview Simulation
|
OLSEN, DALE
|
SIMMERSION, LLC.
|
MD
|
$163,179
|
|
Methamphetamine
|
NIDA
|
1R43DA025376-01
|
|
Online Methamphetamine Abuse Training for Drug Court Professionals
|
LIBERTY, HILARY
|
SOCIAL SCIENCES INNOVATIONS CORPORATION
|
NY
|
$162,027
|
|
Methamphetamine
|
NIDA
|
1F31DA025422-01
|
|
Emotion Regulation and Aggression During Early Abstinence from Methamphetamine
|
PAYER, DORIS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$29,436
|
|
Methamphetamine
|
NIDA
|
1R21DA025441-01
|
|
ATS Use & HIV Among Young Female Sex and Entertainment Workers in Cambodia
|
PAGE-SHAFER, KIMBERLY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$128,606
|
|
Methamphetamine
|
NIDA
|
1R21DA025477-01
|
|
Methamphetamine and HIV Infection
|
HO, WENZHE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$134,860
|
|
Methamphetamine
|
NIDA
|
1R21DA024979-01A1
|
|
METH-induced T cell Dysfunction: Role in HIV-1 Immunopathogenesis
|
POTULA, RAGHAVA
|
TEMPLE UNIVERSITY
|
PA
|
$225,000
|
|
Methamphetamine
|
NIDA
|
1R01DA025591-01
|
|
GABAA Modulation as a Target for Developing Medications for Methamphetamine Abuse
|
RUSH, CRAIG
|
UNIVERSITY OF KENTUCKY
|
KY
|
$329,625
|
|
Methamphetamine
|
NIDA
|
5P50DA018185-04
|
0001
|
Trials of Medications for Stimulant Abuse Research Plan
|
NEWTON, THOMAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$379,148
|
|
Methamphetamine
|
NIDA
|
5P50DA018185-04
|
0002
|
Trials of Medication For Stimulant Abuse
|
SHOPTAW, STEVEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$724,837
|
|
Methamphetamine
|
NIDA
|
1R03DA025950-01
|
|
Methamphetamine Induces a Complex Microglia-Neuronal Crosstalk
|
AIZENMAN, ELIAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$75,750
|
|
Methamphetamine
|
NIMH
|
5P30MH062512-08
|
9005
|
Neuroimaging Core
|
GRANT, IGOR
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$141,700
|
|
Methamphetamine
|
NIDA
|
1R03DA025985-01
|
|
A Life Course Perspective Model of HIV Risk and Substance Use Patterns among MSM
|
SWARTZ, JAMES
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$157,000
|
|
Methamphetamine
|
NIDA
|
1R21DA026053-01
|
|
Role of TNFalpha in Synaptic Homeostasis in Response to Drugs of Abuse
|
MURAI, KEITH
|
MCGILL UNIVERSITY
|
CANADA
|
$82,067
|
|
Methamphetamine
|
NIDA
|
1R21DA024797-01A1
|
|
Amphetamine Regulation of DAT Function in c.elegans
|
CARVELLI, LUCIA
|
VANDERBILT UNIVERSITY
|
TN
|
$230,100
|
|
Methamphetamine
|
NIDA
|
5P50DA018179-04
|
0001
|
Evaluation of Adrenergic Pharmacotherapies for d-MA Dependence
|
MENDELSON, JOHN
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$444,908
|
|
Methamphetamine
|
NIDA
|
5P50DA018179-04
|
0002
|
Adrenergic Agents for Methamphetamine: Outpatient Trials
|
GALLOWAY, GANTT
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$397,600
|
|
Methamphetamine
|
NIDA
|
5F31DA023306-02
|
|
mGluR5 Regulation of METH Reward and Sensorimotor Gating
|
HERROLD, AMY
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$25,753
|
|
Methamphetamine
|
NIDA
|
1P01DA026146-01
|
0001
|
METH, HIV-1 and Glial Crosstalk
|
GENDELMAN, HOWARD
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$144,409
|
|
Methamphetamine
|
NIDA
|
1P01DA026146-01
|
0002
|
METH and the Neuropathogenesis of SIV Infection
|
FOX, HOWARD
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$140,226
|
|
Methamphetamine
|
NIDA
|
1P01DA026146-01
|
0003
|
Biomarkers in an HIV-1 Infected Drug Abusing Clinical Cohort
|
CIBOROWSKI, PAWEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$291,722
|
|
Methamphetamine
|
NIDA
|
1P01DA026146-01
|
9002
|
Proteomics Core
|
SIUZDAK, GARY
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$8
|
|
Methamphetamine
|
NIDA
|
3U10DA013711-05S6
|
|
NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK
|
HUBBARD, ROBERT
|
DUKE UNIVERSITY
|
NC
|
$57,448
|
|
Methamphetamine
|
NIDA
|
1R01DA026325-01
|
|
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS
|
DEWHURST, STEPHEN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$259,875
|
|
Methamphetamine
|
NIAAA
|
5P50AA012870-08
|
5850
|
A PET Study of Ventral Striatum Dopamine Release Deficits
|
KRYSTAL, JOHN
|
YALE UNIVERSITY
|
CT
|
$176,585
|
|
Methamphetamine
|
NIDA
|
1R01DA025011-01A1
|
|
Methamphetamine and AIDS in a Non-Human Primate Model
|
KUMAR, ANIL
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
MO
|
$493,284
|
|
Methamphetamine
|
NIDA
|
5P01DA012065-09
|
0006
|
NEUROCOGNITIVE
|
HEATON, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$355,741
|
|
Methamphetamine
|
NIDA
|
5P01DA012065-09
|
0007
|
NEUROMOTOR
|
CALIGIURI, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$14,761
|
|
Methamphetamine
|
NIDA
|
5P01DA012065-09
|
0008
|
fMRI
|
JERNIGAN, TERRY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$193,383
|
|
Methamphetamine
|
NIDA
|
5P01DA012065-09
|
0009
|
13C SPECTROSCOPY
|
ROSS, BRIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$253,546
|
|
Methamphetamine
|
NIDA
|
3U10DA013045-08S1
|
|
National Drug Abuse Treatment Clinical Trials Network
|
LING, WALTER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$397,904
|
|
Methamphetamine
|
NIDA
|
3R01DA019559-04S1
|
|
Intranasal Methamphetamine: A Pharmacotherapy Model
|
HART, CARL
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$7,020
|
|
Methamphetamine
|
NIDA
|
5P50DA005312-18
|
0011
|
INDIVIDUAL DIFFERENCES IN RESPONSE TO AMPHETAMINE
|
BARDO, MICHAEL
|
UNIVERSITY OF KENTUCKY
|
KY
|
$293,922
|
|
Methamphetamine
|
NIA
|
5P01AG023630-04
|
0002
|
METHAMPHETAMINE AND GDNF/BDNF IN AGED DOPAMINE SYSTEMS
|
MCGINTY, JACQUELINE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$173,915
|
|
Methamphetamine
|
NIA
|
5P01AG023630-04
|
0004
|
DOPAMINE AND VESICULAR MONOAMINE TRANSPORTERS IN AGING
|
RAMAMOORTHY, SAMMANDA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$157,962
|
|
Methamphetamine
|
NIA
|
5P01AG023630-04
|
0005
|
GDNF AND BDNF EFFECTS ON AGE ISOLATED DOPAMINE NEURONS
|
GRANHOLM-BENTLEY, ANN-CHARLOTTE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$184,495
|
|
Methamphetamine
|
NIDA
|
271200700014C-1-0-1
|
|
Rodent Drug Discrimination and Locomotor Activity Testing (RFC, N01DA-7-8872)
|
NO PI IDENTIFIED
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$627,561
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
0001
|
NEUROCHEMICAL INVOLVEMENT OF METHAMPHETAMINE SEEKING IN MICE
|
MARK, GREGORY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$194,332
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
0002
|
PSYCHOSTIMULANT REWARD AND SENSITIZATION
|
PHILLIPS, TAMARA
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$196,478
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
0003
|
PHARMACOTHERAPY TO PREVENT METHAMPHETAMINE RELAPSE
|
BERGER, PAUL
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$156,947
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
0004
|
PILOT PROJECTS 8A, 8B AND 8C
|
PHILLIPS, TAMARA
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$97,476
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
9001
|
BIOSTATISTICS CORE
|
SEXTON, GARY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$67,329
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
9002
|
ANIMAL CORE
|
CRABBE, JOHN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$75,636
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
9003
|
EDUCATION CORE
|
CAMERON, WILLIAM
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$72,987
|
|
Methamphetamine
|
FIC
|
7R21DA021422-03
|
|
Brain Changes with Cannabis and Methamphetamine
|
YURGELUN-TODD, DEBORAH
|
UNIVERSITY OF UTAH
|
UT
|
$9,800
|
|
Methamphetamine
|
NIDA
|
7R21DA021422-03
|
|
Brain Changes with Cannabis and Methamphetamine
|
YURGELUN-TODD, DEBORAH
|
UNIVERSITY OF UTAH
|
UT
|
$103,509
|
|
Methamphetamine
|
NIDA
|
7R01DA007606-17
|
|
Methamphetamine Toxicity and Corticostriatal Glutamate
|
YAMAMOTO, BRYAN
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$176,462
|
|
Methamphetamine
|
NIDA
|
3R01DA023395-02S1
|
|
Intervention Targeting Medication Adherence and Methamphetamine Use for HIV + Men
|
PARSONS, JEFFREY
|
HUNTER COLLEGE
|
NY
|
$75,257
|
|
Methamphetamine
|
NIDA
|
3R01DA015041-06S1
|
|
Optimizing Intensity and Duration of GVG Pharmacotherapy
|
DEWEY, STEPHEN
|
BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB
|
NY
|
$52,066
|
|
Methamphetamine
|
NIDA
|
3R01DA020726-03S1
|
|
Neural Systems, Inhibitory Control, and Methamphetamine Dependence
|
LONDON, EDYTHE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$120,508
|
|
Methamphetamine
|
NIDA
|
3R01DA024441-02S1
|
|
Methamphetamine, Stress and SIV: Effects at Blood-Brain Barrier and Lymph Nodes
|
CAPITANIO, JOHN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$139,527
|
|
Methamphetamine
|
NIDA
|
N01DA78863-4-0-1
|
|
Medications Development for Stimulant Dependence
|
NO PI IDENTIFIED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$1,138,487
|
|
Methamphetamine
|
NIDA
|
N01DA38838-17-0-1
|
|
Medications Development of Stimulant Dependence
|
NO PI IDENTIFIED
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$133,491
|
|
Methamphetamine
|
NIDA
|
271200700002C-3-0-1
|
|
Funding for new contract - N01DA-7-8860
|
NO PI IDENTIFIED
|
|
|
$229,100
|
|
Methamphetamine
|
NIDA
|
5P20DA022539-03
|
0001
|
INHIBITORY CONTROL AND METHAMPHETAMINE DEPENDENCE MODAFINIL EFFECTS
|
LONDON, EDYTHE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$1
|
|
Methamphetamine
|
NIDA
|
5P20DA022539-03
|
0002
|
INHIBITORY CONTROL AND MA SELF-ADMINISTRATION MODAFINIL EFFECTS
|
NEWTON, THOMAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$117,902
|
|
Methamphetamine
|
NIDA
|
5P20DA022539-03
|
0003
|
NEUROCHEMICAL DETERMINANTS OF MA-INDUCED COGNITIVE DEFICITS
|
JENTSCH, J
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$176,731
|
|
Methamphetamine
|
NIDA
|
5P20DA022539-03
|
0004
|
NEUROCHEMISTRY OF MODAFINIL-MA INTERACTION IN RAT BRAIN
|
KUCZENSKI, RONALD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$753,463
|
|
Methamphetamine
|
NIDA
|
5P20DA022658-03
|
0001
|
PRECLINICAL CIRCUITRY UNDERLYING METHAPHETAMINE ADDICTION
|
KALIVAS, PETER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$102,095
|
|
Methamphetamine
|
NIDA
|
5P20DA022658-03
|
0002
|
CLINICAL CIRCUITRY UNDERLYING METHAMPHETAMINE ADDICTION
|
MALCOLM, ROBERT
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$213,100
|
|
Methamphetamine
|
NIDA
|
5P20DA022658-03
|
0003
|
PRECLINICAL MEASURES OF METH-INDUCED EXTINCTION, DRUG-SEEKING AND COGNITION
|
SEE, RONALD%
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$107,222
|
|
Methamphetamine
|
NIDA
|
5P20DA022658-03
|
0004
|
CLINICAL MEASURES OF METH-INDUCED EXTINCTION, DRUG INTEREST, AND COGNITION
|
BRADY, KATHLEEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$196,749
|
|
Methamphetamine
|
NIDA
|
5U54NS039406-10
|
0006
|
Methamphetamine psychosis: A model in man and mouse
|
ALICATA, DANIEL
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$85,059
|
|
Methamphetamine
|
NIMH
|
5U54NS039406-10
|
0006
|
Methamphetamine psychosis: A model in man and mouse
|
ALICATA, DANIEL
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$141,765
|
|
Methamphetamine
|
NINDS
|
5U54NS039406-10
|
0006
|
Methamphetamine psychosis: A model in man and mouse
|
ALICATA, DANIEL
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$339,885
|
|
Methamphetamine
|
NIDA
|
5U54NS039406-10
|
9001
|
Scientific Core: Peptide and DNA technology core
|
SPIESS, JOACHIM
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$69,975
|
|
Methamphetamine
|
NIMH
|
5U54NS039406-10
|
9001
|
Scientific Core: Peptide and DNA technology core
|
SPIESS, JOACHIM
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$116,625
|
|
Methamphetamine
|
NINDS
|
5U54NS039406-10
|
9001
|
Scientific Core: Peptide and DNA technology core
|
SPIESS, JOACHIM
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$279,613
|
|
Methamphetamine
|
NIDA
|
5P50DA018165-03
|
9004
|
Administrative Core
|
JANOWSKY, AARON
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$101,604
|
|
Methamphetamine
|
NCMHD
|
Y1MD6058-3-0-1
|
|
Indian Country Methamphetamine Initiative
|
NO PI IDENTIFIED
|
|
|
$1,000,000
|
|
Methamphetamine
|
NCRR
|
2P51RR000168-47
|
5638
|
TRACE AMINE-ASSOCIATED RECEPTOR 1, A TARGET FOR DRUG ADDICTION THERAPEUTICS
|
MILLER, GREGORY
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$19,465
|
|
Methamphetamine
|
NCRR
|
2P51RR000168-47
|
5639
|
METHAMPHETAMINE EFFECTS VIA TRACE AMINE ASSOCIATED RECEPTOR 1
|
MILLER, GREGORY
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$19,465
|
|
Methamphetamine
|
NCRR
|
2P51RR000168-47
|
5644
|
A MONKEY MODEL OF HUMAN MU-OPIOID RECEPTOR PHYSIOGENETICS
|
MILLER, GREGORY
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$19,465
|
|
Methamphetamine
|
NCRR
|
5P51RR000169-47
|
5801
|
METHAMPHETAMINE, STRESS AND SIV: EFFECTS AT BLOOD-BRAIN BARRIER AND LYMPH NODES
|
CAPITANIO, JOHN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$167,228
|
|
Methamphetamine
|
NIA
|
5P51RR000169-47
|
5801
|
METHAMPHETAMINE, STRESS AND SIV: EFFECTS AT BLOOD-BRAIN BARRIER AND LYMPH NODES
|
CAPITANIO, JOHN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$1,767
|
|
Methamphetamine
|
NCRR
|
5M01RR000425-39
|
7370
|
PRENATAL METHAMPHETAMINE EXPOSURE AND CHILD DEVELOPMENT
|
SMITH, LYNNE
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$64,618
|
|
Methamphetamine
|
NCRR
|
5M01RR000425-39
|
7379
|
METHAMPHETAMINE EFFECTS IN BRAIN DOPAMINE ACTIVITY
|
SMITH, LYNNE
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$7,309
|
|
Methamphetamine
|
NCRR
|
5M01RR000425-39
|
7388
|
ACUPUNCTURE FOR TREATMENT OF METHAMPHETAMINE WITHDRAWAL SYMPTOMS: NO METHOD
|
HO, ANDREW
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$730
|
|
Methamphetamine
|
NCRR
|
5M01RR000865-35
|
8084
|
EARLY METHAMPHETAMINE ABSTINENCE: FMRI AND COGNITION
|
LONDON, EDYTHE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$34,936
|
|
Methamphetamine
|
NCRR
|
5M01RR000865-35
|
8126
|
NEURAL SYSTEMS, INHIBITORY CONTROL, AND METHAMPHETAMINE DEPENDENCE (IRB #05-0
|
LONDON, EDYTHE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$245,974
|
|
Methamphetamine
|
NCRR
|
5M01RR000865-35
|
8132
|
ASSESSMENT OF GVG FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE
|
NEWTON, THOMAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$342,224
|
|
Methamphetamine
|
NCRR
|
5M01RR000865-35
|
8134
|
MODAFINIL AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE: INITIAL SAFETY, SUBJ
|
NEWTON, THOMAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$144,732
|
|
Methamphetamine
|
NCRR
|
5M01RR000865-35
|
8137
|
EFFECTS OF CHRONIC METHAMPHETAMINE USE ON SLEEP
|
NEWTON, THOMAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$97,676
|
|
Methamphetamine
|
NCRR
|
5M01RR000865-35
|
8146
|
METHAMPHETAMINE DEPENDENCE: A NOVEL LABORATORY MODEL
|
NEWTON, THOMAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$398,796
|
|
Methamphetamine
|
NCRR
|
5M01RR010710-11
|
8388
|
CLINICAL TRIAL: METHAMPHETAMINE EFFECTS IN BRAIN DOPAMINE ACTIVITY
|
WANG, GENE-JACK
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$8,358
|
|
Methamphetamine
|
NCRR
|
5M01RR010710-11
|
8432
|
PET STUDIES OF THE PHARMACOKINETICS OF D-METHAMPHETAMINE IN THE HUMAN BODY
|
FOWLER, JOANNA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$22,044
|
|
Methamphetamine
|
NCRR
|
5M01RR001070-31
|
5825
|
CLINICAL CIRCUITRY UNDERLYING METHAMPHETAMINE CUE CRAVING AND CUE EXTINCTION
|
MALCOLM, ROBERT
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$31,774
|
|
Methamphetamine
|
NCRR
|
5P20RR016481-08
|
6266
|
BEHAVIOR AND MECHANISM IN ACUTE AMPHETAMINE WITHDRAWAL
|
WHITE, WESLEY
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$156,364
|
|
Methamphetamine
|
NCRR
|
5P20RR016475-08
|
6324
|
INBRE: KU-L: THE IMPACT OF DOPAMINE SIGNALING ON FRAGILE X SYNDROME BEHAVIORS
|
JOHNSON, MICHAEL
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$125,131
|
|
Methamphetamine
|
NCRR
|
5P20RR017696-07
|
6927
|
ORAL EFFECTS OF METHAMPHETAMINE USE: A STUDY OF "METH MOUTH"
|
RAVENEL, MICHELE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$15,934
|
|
Methamphetamine
|
NCRR
|
5P41RR013642-11
|
6707
|
BRAIN AND BEHAVIORAL ALTERATIONS AFTER METHAMPHETAMINE
|
MELEGA, WILLIAM
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$5,153
|
|
Methamphetamine
|
NCRR
|
5U54RR014607-10
|
6905
|
METH USE AND SMOKING IN PREGNANCY
|
WRIGHT, TRICIA
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$137,477
|
|
Methamphetamine
|
NCRR
|
5M01RR000827-33
|
7051
|
EFFECTS OF METHAMPHETAMINE & HCV
|
GRANT, IGOR
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$424,754
|
|
Methamphetamine
|
NCRR
|
5P20RR016469-08
|
7319
|
DESIGN OF COLORIMETRIC AND CHIROPTICAL SENSORS FOR ABUSED NARCOTICS
|
HOLMES, ANDREA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$23,413
|
|
Methamphetamine
|
NCRR
|
5P20RR011091-14
|
7428
|
PRENATAL METHAMPHETAMINE EXPOSURE AND CHILD DEVELOPMENT (IDEAL)
|
DERAUF, D
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$17,806
|
|
Methamphetamine
|
NCRR
|
5P20RR011091-14
|
7434
|
NEURODEVELOPMENT
|
DERAUF, D
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$89,032
|
|
Methamphetamine
|
NCRR
|
5P20RR011091-14
|
7454
|
IDEAL2
|
DERAUF, D
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$17,806
|
|
Methamphetamine
|
NIDA
|
1Z01DA000003-23
|
|
Drugs On Learned & Spontaneous Behavior Of Experimental Animals
|
GOLDBERG, STEVEN
|
NIH
|
|
$1,347,861
|
|
Methamphetamine
|
NIDA
|
1Z01DA000174-14
|
|
cDNA Array Analysis of Cu/Zn SOD Tg Mice Treated with Neurotoxic Doses of AMPH
|
CADET, JEAN
|
NIH
|
|
$550,346
|
|
Methamphetamine
|
NIDA
|
1Z01DA000401-11
|
|
Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Humans
|
UHL, GEORGE
|
NIH
|
|
$1,948,128
|
|
Methamphetamine
|
NIDA
|
1Z01DA000429-10
|
|
Neuroprotective and neuroregenerative effects of Bone morphogenetic proteins
|
WANG, YUN
|
NIH
|
|
$497,686
|
|
Methamphetamine
|
NIDA
|
1Z01DA000443-08
|
|
Gene Therapy And Neurodegeneration
|
HARVEY, BRANDON
|
NIH
|
|
$497,686
|
|
Methamphetamine
|
NIDA
|
1Z01DA000445-08
|
|
Brain Temperature, Reward, And Drugs Of Abuse
|
KIYATKIN, EUGENE
|
NIH
|
|
$1,095,822
|
|
Methamphetamine
|
NIDA
|
1Z01DA000461-06
|
|
Neuroprotective/regenerative effects of small molecules and trophic factors
|
WANG, YUN
|
NIH
|
|
$497,686
|
|
Methamphetamine
|
NIDA
|
1Z01DA000478-04
|
|
Basic brain mechanisms underlying drug addiction, craving, and relapse
|
GARDNER, ELIOT
|
NIH
|
|
$311,701
|
|
Methamphetamine
|
NIDA
|
1Z01DA000494-02
|
|
Methamphetamine Administration Causes Death of Dopaminergic Neurons in the Mouse
|
CADET, JEAN
|
NIH
|
|
$550,346
|
|
Methamphetamine
|
NIDA
|
1Z01DA000495-02
|
|
Serial analysis of gene expression in the rat striatum following methamphetamine
|
CADET, JEAN
|
NIH
|
|
$550,346
|
|
Methamphetamine
|
NIDA
|
1Z01DA000498-02
|
|
Meth causes alterations in the MAP kinase-related pathways in the brains of mice
|
CADET, JEAN
|
NIH
|
|
$550,346
|
|
Methamphetamine
|
NIDA
|
1Z01DA000540-02
|
|
Role of multidrug resistance protein 1a (MDR1a) in methamphetamine and methylened
|
SCHEIDWEILER, KARL
|
NIH
|
|
$325,824
|
|
Methamphetamine
|
NIDA
|
1Z01DA000521-01
|
|
Studies of Biogenic Amine Transporter Inhibitors
|
ROTHMAN, RICHARD
|
NIH
|
|
$199,196
|
|
Methamphetamine
|
NIDA
|
1Z01DA000522-01
|
|
Development of Dual Dopamine/Serotonin Releasing Agents
|
ROTHMAN, RICHARD
|
NIH
|
|
$597,588
|
|
Methamphetamine
|
NIDA
|
1Z01DA000526-01
|
|
Gene Delivery and Addiction
|
HARVEY, BRANDON
|
NIH
|
|
$497,686
|
|
Methamphetamine
|
NIDA
|
1Z01DA000532-01
|
|
Medicinal Chemistry of Drugs Acting on Biogenic Amine Receptors
|
RICE, KENNER
|
NIH
|
|
$116,888
|
|
